Aberdeen Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.55M | Buy |
81,916
+17,962
| +28% | +$1.88M | 0.01% | 631 |
|
|
2025
Q1 | $7.46M | Sell |
63,954
-8,225
| -11% | -$959K | 0.01% | 628 |
|
|
2024
Q4 | $6.11M | Buy |
72,179
+61,131
| +553% | +$5.17M | 0.01% | 613 |
|
|
2024
Q3 | $993K | Sell |
11,048
-28,627
| -72% | -$2.57M | ﹤0.01% | 810 |
|
|
2024
Q2 | $3.19M | Buy |
+39,675
| New | +$3.19M | 0.01% | 700 |
|